View Financial HealthEmdeki Utama 배당 및 자사주 매입배당 기준 점검 2/6Emdeki Utama 수익으로 충분히 충당되는 현재 수익률 4.19% 보유한 배당금 지급 회사입니다.핵심 정보4.2%배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향73%최근 배당 및 자사주 매입 업데이트공시 • May 28PT Emdeki Utama Tbk announces Annual dividend, payable on June 25, 2025PT Emdeki Utama Tbk announced Annual dividend of IDR 8.0000 per share payable on June 25, 2025, ex-date on June 04, 2025 and record date on June 05, 2025.Upcoming Dividend • May 31Upcoming dividend of Rp12.00 per shareEligible shareholders must have bought the stock before 07 June 2021. Payment date: 25 June 2021. Trailing yield: 4.2%. Lower than top quartile of Indonesian dividend payers (4.8%). Higher than average of industry peers (0.3%).모든 업데이트 보기Recent updatesReported Earnings • May 05First quarter 2026 earnings released: EPS: Rp2.00 (vs Rp3.96 in 1Q 2025)First quarter 2026 results: EPS: Rp2.00 (down from Rp3.96 in 1Q 2025). Revenue: Rp71.6b (down 2.8% from 1Q 2025). Net income: Rp6.30b (down 37% from 1Q 2025). Profit margin: 8.8% (down from 14% in 1Q 2025). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.공시 • Apr 25PT Emdeki Utama Tbk, Annual General Meeting, Jun 02, 2026PT Emdeki Utama Tbk, Annual General Meeting, Jun 02, 2026.Reported Earnings • Apr 02Full year 2025 earnings released: EPS: Rp14.00 (vs Rp10.89 in FY 2024)Full year 2025 results: EPS: Rp14.00 (up from Rp10.89 in FY 2024). Revenue: Rp319.2b (down 7.3% from FY 2024). Net income: Rp34.4b (up 25% from FY 2024). Profit margin: 11% (up from 8.0% in FY 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.Reported Earnings • Nov 04Third quarter 2025 earnings released: EPS: Rp2.89 (vs Rp3.13 in 3Q 2024)Third quarter 2025 results: EPS: Rp2.89 (down from Rp3.13 in 3Q 2024). Revenue: Rp78.4b (down 17% from 3Q 2024). Net income: Rp6.26b (down 21% from 3Q 2024). Profit margin: 8.0% (down from 8.4% in 3Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.Board Change • Oct 24No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Independent Commissioner Sjaiful Arifin was the last independent director to join the board, commencing their role in 2017. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.공시 • May 28PT Emdeki Utama Tbk announces Annual dividend, payable on June 25, 2025PT Emdeki Utama Tbk announced Annual dividend of IDR 8.0000 per share payable on June 25, 2025, ex-date on June 04, 2025 and record date on June 05, 2025.공시 • May 01PT Emdeki Utama Tbk, Annual General Meeting, May 22, 2025PT Emdeki Utama Tbk, Annual General Meeting, May 22, 2025. Location: hotel aston prioritysimatupang, skyballroom priority1, lantai 26, jl let.jend., t.b. simatupang kav 9, kebagusan, jakarta selatan, 12520 kota adm. jakarta selatan dki., jakarta IndonesiaReported Earnings • Aug 02Second quarter 2024 earnings released: EPS: Rp0.99 (vs Rp4.08 in 2Q 2023)Second quarter 2024 results: EPS: Rp0.99 (down from Rp4.08 in 2Q 2023). Revenue: Rp64.5b (down 45% from 2Q 2023). Net income: Rp2.48b (down 76% from 2Q 2023). Profit margin: 3.9% (down from 8.8% in 2Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.공시 • May 18PT Emdeki Utama Tbk, Annual General Meeting, Jun 24, 2024PT Emdeki Utama Tbk, Annual General Meeting, Jun 24, 2024.Reported Earnings • May 04First quarter 2024 earnings released: EPS: Rp3.00 (vs Rp5.22 in 1Q 2023)First quarter 2024 results: EPS: Rp3.00 (down from Rp5.22 in 1Q 2023). Revenue: Rp85.0b (down 20% from 1Q 2023). Net income: Rp8.85b (down 33% from 1Q 2023). Profit margin: 10% (down from 12% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Reported Earnings • Apr 04Full year 2023 earnings released: EPS: Rp19.00 (vs Rp15.00 in FY 2022)Full year 2023 results: EPS: Rp19.00 (up from Rp15.00 in FY 2022). Revenue: Rp470.7b (down 3.3% from FY 2022). Net income: Rp47.8b (up 26% from FY 2022). Profit margin: 10% (up from 7.8% in FY 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Reported Earnings • Nov 05Third quarter 2023 earnings released: EPS: Rp4.70 (vs Rp3.65 in 3Q 2022)Third quarter 2023 results: EPS: Rp4.70 (up from Rp3.65 in 3Q 2022). Revenue: Rp121.8b (up 1.5% from 3Q 2022). Net income: Rp12.0b (up 30% from 3Q 2022). Profit margin: 9.8% (up from 7.7% in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 8% per year.Reported Earnings • Aug 05Second quarter 2023 earnings released: EPS: Rp4.08 (vs Rp2.30 in 2Q 2022)Second quarter 2023 results: EPS: Rp4.08 (up from Rp2.30 in 2Q 2022). Revenue: Rp117.5b (flat on 2Q 2022). Net income: Rp10.3b (up 78% from 2Q 2022). Profit margin: 8.8% (up from 5.0% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 9% per year whereas the company’s share price has increased by 11% per year.Reported Earnings • Apr 06Full year 2022 earnings released: EPS: Rp15.00 (vs Rp15.30 in FY 2021)Full year 2022 results: EPS: Rp15.00 (down from Rp15.30 in FY 2021). Revenue: Rp486.9b (up 23% from FY 2021). Net income: Rp38.0b (down 2.0% from FY 2021). Profit margin: 7.8% (down from 9.7% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 4% per year.Board Change • Nov 16Less than half of directors are independentThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. 4 experienced directors. 1 highly experienced director. 1 independent director (2 non-independent directors). Director Vincent Secapramana is the most experienced director on the board, commencing their role in 2010. Independent Commissioner Sjaiful Arifin was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.Reported Earnings • Aug 05Second quarter 2022 earnings released: EPS: Rp2.34 (vs Rp2.85 in 2Q 2021)Second quarter 2022 results: EPS: Rp2.34 (down from Rp2.85 in 2Q 2021). Revenue: Rp116.8b (up 17% from 2Q 2021). Net income: Rp5.82b (down 19% from 2Q 2021). Profit margin: 5.0% (down from 7.2% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.Reported Earnings • Jun 02First quarter 2022 earnings released: EPS: Rp2.40 (vs Rp2.21 in 1Q 2021)First quarter 2022 results: EPS: Rp2.40 (up from Rp2.21 in 1Q 2021). Revenue: Rp109.1b (up 25% from 1Q 2021). Net income: Rp5.98b (up 6.9% from 1Q 2021). Profit margin: 5.5% (down from 6.4% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.Board Change • Apr 27Less than half of directors are independentThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. 4 experienced directors. 1 highly experienced director. 1 independent director (2 non-independent directors). Director Vincent Secapramana is the most experienced director on the board, commencing their role in 2010. Independent Commissioner Sjaiful Arifin was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.Reported Earnings • Apr 08Full year 2021 earnings released: EPS: Rp15.00 (vs Rp15.75 in FY 2020)Full year 2021 results: EPS: Rp15.00 (down from Rp15.75 in FY 2020). Revenue: Rp397.3b (up 14% from FY 2020). Net income: Rp38.7b (down 2.8% from FY 2020). Profit margin: 9.7% (down from 11% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.Upcoming Dividend • May 31Upcoming dividend of Rp12.00 per shareEligible shareholders must have bought the stock before 07 June 2021. Payment date: 25 June 2021. Trailing yield: 4.2%. Lower than top quartile of Indonesian dividend payers (4.8%). Higher than average of industry peers (0.3%).Reported Earnings • Apr 09Full year 2020 earnings released: EPS Rp16.00 (vs Rp12.83 in FY 2019)The company reported a solid full year result with improved earnings and profit margins, although revenues were flat. Full year 2020 results: Revenue: Rp350.0b (flat on FY 2019). Net income: Rp39.8b (up 23% from FY 2019). Profit margin: 11% (up from 9.3% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 6% per year.Valuation Update With 7 Day Price Move • Feb 11Investor sentiment improved over the past weekAfter last week's 27% share price gain to Rp280, the stock is trading at a trailing P/E ratio of 22.3x, up from the previous P/E ratio of 17.5x. This compares to an average P/E of 16x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 40%.Valuation Update With 7 Day Price Move • Dec 30Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to Rp232, the stock is trading at a trailing P/E ratio of 18.4x, down from the previous P/E ratio of 22.6x. This compares to an average P/E of 17x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 33%.Valuation Update With 7 Day Price Move • Dec 18Investor sentiment improved over the past weekAfter last week's 33% share price gain to Rp238, the stock is trading at a trailing P/E ratio of 18.9x, up from the previous P/E ratio of 14.2x. This compares to an average P/E of 15x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 39%.Is New 90 Day High Low • Dec 08New 90-day high: Rp180The company is up 7.0% from its price of Rp168 on 09 September 2020. The Indonesian market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 37% over the same period.Valuation Update With 7 Day Price Move • Nov 28Market bids up stock over the past weekAfter last week's 18% share price gain to Rp179, the stock is trading at a trailing P/E ratio of 14.2x, up from the previous P/E ratio of 12.1x. This compares to an average P/E of 13x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 2.1%.Is New 90 Day High Low • Nov 12New 90-day low: Rp140The company is down 10.0% from its price of Rp156 on 14 August 2020. The Indonesian market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.Reported Earnings • Nov 03Third quarter 2020 earnings released: EPS Rp6.38The company reported a soft third quarter result with weaker earnings and revenues, although profit margins were improved. Third quarter 2020 results: Revenue: Rp94.8b (down 8.8% from 3Q 2019). Net income: Rp16.3b (down 2.6% from 3Q 2019). Profit margin: 17% (up from 16% in 3Q 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: MDKI 10년 미만 동안 배당금을 지급해 왔으며 이 기간 동안 지급액은 휘발성이었습니다.배당금 증가: MDKI 7 년 동안만 배당금을 지급해 왔으며 그 이후 지급액이 감소했습니다.배당 수익률 vs 시장Emdeki Utama 배당 수익률 vs 시장MDKI의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (MDKI)4.2%시장 하위 25% (ID)1.2%시장 상위 25% (ID)6.5%업계 평균 (Chemicals)0.7%분석가 예측 (MDKI) (최대 3년)n/a주목할만한 배당금: MDKI 의 배당금( 4.19% )은 ID 시장에서 배당금 지급자의 하위 25%( 1.17% )보다 높습니다.고배당: MDKI 의 배당금( 4.19% )은 ID 시장에서 배당금 지급자의 상위 25%( 6.46% )와 비교해 낮습니다.주주 대상 이익 배당수익 보장: 합리적인 지급 비율 ( 73.5% )을 통해 MDKI 의 배당금 지급은 수익으로 충당됩니다.주주 현금 배당현금 흐름 범위: 현금 지급 비율 ( 94.7% )이 높기 때문에 MDKI 의 배당금 지급은 현금 흐름으로 잘 충당되지 않습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YID 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 17:41종가2026/05/22 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스PT Emdeki Utama Tbk는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • May 28PT Emdeki Utama Tbk announces Annual dividend, payable on June 25, 2025PT Emdeki Utama Tbk announced Annual dividend of IDR 8.0000 per share payable on June 25, 2025, ex-date on June 04, 2025 and record date on June 05, 2025.
Upcoming Dividend • May 31Upcoming dividend of Rp12.00 per shareEligible shareholders must have bought the stock before 07 June 2021. Payment date: 25 June 2021. Trailing yield: 4.2%. Lower than top quartile of Indonesian dividend payers (4.8%). Higher than average of industry peers (0.3%).
Reported Earnings • May 05First quarter 2026 earnings released: EPS: Rp2.00 (vs Rp3.96 in 1Q 2025)First quarter 2026 results: EPS: Rp2.00 (down from Rp3.96 in 1Q 2025). Revenue: Rp71.6b (down 2.8% from 1Q 2025). Net income: Rp6.30b (down 37% from 1Q 2025). Profit margin: 8.8% (down from 14% in 1Q 2025). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
공시 • Apr 25PT Emdeki Utama Tbk, Annual General Meeting, Jun 02, 2026PT Emdeki Utama Tbk, Annual General Meeting, Jun 02, 2026.
Reported Earnings • Apr 02Full year 2025 earnings released: EPS: Rp14.00 (vs Rp10.89 in FY 2024)Full year 2025 results: EPS: Rp14.00 (up from Rp10.89 in FY 2024). Revenue: Rp319.2b (down 7.3% from FY 2024). Net income: Rp34.4b (up 25% from FY 2024). Profit margin: 11% (up from 8.0% in FY 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
Reported Earnings • Nov 04Third quarter 2025 earnings released: EPS: Rp2.89 (vs Rp3.13 in 3Q 2024)Third quarter 2025 results: EPS: Rp2.89 (down from Rp3.13 in 3Q 2024). Revenue: Rp78.4b (down 17% from 3Q 2024). Net income: Rp6.26b (down 21% from 3Q 2024). Profit margin: 8.0% (down from 8.4% in 3Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
Board Change • Oct 24No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Independent Commissioner Sjaiful Arifin was the last independent director to join the board, commencing their role in 2017. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • May 28PT Emdeki Utama Tbk announces Annual dividend, payable on June 25, 2025PT Emdeki Utama Tbk announced Annual dividend of IDR 8.0000 per share payable on June 25, 2025, ex-date on June 04, 2025 and record date on June 05, 2025.
공시 • May 01PT Emdeki Utama Tbk, Annual General Meeting, May 22, 2025PT Emdeki Utama Tbk, Annual General Meeting, May 22, 2025. Location: hotel aston prioritysimatupang, skyballroom priority1, lantai 26, jl let.jend., t.b. simatupang kav 9, kebagusan, jakarta selatan, 12520 kota adm. jakarta selatan dki., jakarta Indonesia
Reported Earnings • Aug 02Second quarter 2024 earnings released: EPS: Rp0.99 (vs Rp4.08 in 2Q 2023)Second quarter 2024 results: EPS: Rp0.99 (down from Rp4.08 in 2Q 2023). Revenue: Rp64.5b (down 45% from 2Q 2023). Net income: Rp2.48b (down 76% from 2Q 2023). Profit margin: 3.9% (down from 8.8% in 2Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
공시 • May 18PT Emdeki Utama Tbk, Annual General Meeting, Jun 24, 2024PT Emdeki Utama Tbk, Annual General Meeting, Jun 24, 2024.
Reported Earnings • May 04First quarter 2024 earnings released: EPS: Rp3.00 (vs Rp5.22 in 1Q 2023)First quarter 2024 results: EPS: Rp3.00 (down from Rp5.22 in 1Q 2023). Revenue: Rp85.0b (down 20% from 1Q 2023). Net income: Rp8.85b (down 33% from 1Q 2023). Profit margin: 10% (down from 12% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Reported Earnings • Apr 04Full year 2023 earnings released: EPS: Rp19.00 (vs Rp15.00 in FY 2022)Full year 2023 results: EPS: Rp19.00 (up from Rp15.00 in FY 2022). Revenue: Rp470.7b (down 3.3% from FY 2022). Net income: Rp47.8b (up 26% from FY 2022). Profit margin: 10% (up from 7.8% in FY 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Reported Earnings • Nov 05Third quarter 2023 earnings released: EPS: Rp4.70 (vs Rp3.65 in 3Q 2022)Third quarter 2023 results: EPS: Rp4.70 (up from Rp3.65 in 3Q 2022). Revenue: Rp121.8b (up 1.5% from 3Q 2022). Net income: Rp12.0b (up 30% from 3Q 2022). Profit margin: 9.8% (up from 7.7% in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 8% per year.
Reported Earnings • Aug 05Second quarter 2023 earnings released: EPS: Rp4.08 (vs Rp2.30 in 2Q 2022)Second quarter 2023 results: EPS: Rp4.08 (up from Rp2.30 in 2Q 2022). Revenue: Rp117.5b (flat on 2Q 2022). Net income: Rp10.3b (up 78% from 2Q 2022). Profit margin: 8.8% (up from 5.0% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 9% per year whereas the company’s share price has increased by 11% per year.
Reported Earnings • Apr 06Full year 2022 earnings released: EPS: Rp15.00 (vs Rp15.30 in FY 2021)Full year 2022 results: EPS: Rp15.00 (down from Rp15.30 in FY 2021). Revenue: Rp486.9b (up 23% from FY 2021). Net income: Rp38.0b (down 2.0% from FY 2021). Profit margin: 7.8% (down from 9.7% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 4% per year.
Board Change • Nov 16Less than half of directors are independentThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. 4 experienced directors. 1 highly experienced director. 1 independent director (2 non-independent directors). Director Vincent Secapramana is the most experienced director on the board, commencing their role in 2010. Independent Commissioner Sjaiful Arifin was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.
Reported Earnings • Aug 05Second quarter 2022 earnings released: EPS: Rp2.34 (vs Rp2.85 in 2Q 2021)Second quarter 2022 results: EPS: Rp2.34 (down from Rp2.85 in 2Q 2021). Revenue: Rp116.8b (up 17% from 2Q 2021). Net income: Rp5.82b (down 19% from 2Q 2021). Profit margin: 5.0% (down from 7.2% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
Reported Earnings • Jun 02First quarter 2022 earnings released: EPS: Rp2.40 (vs Rp2.21 in 1Q 2021)First quarter 2022 results: EPS: Rp2.40 (up from Rp2.21 in 1Q 2021). Revenue: Rp109.1b (up 25% from 1Q 2021). Net income: Rp5.98b (up 6.9% from 1Q 2021). Profit margin: 5.5% (down from 6.4% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
Board Change • Apr 27Less than half of directors are independentThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. 4 experienced directors. 1 highly experienced director. 1 independent director (2 non-independent directors). Director Vincent Secapramana is the most experienced director on the board, commencing their role in 2010. Independent Commissioner Sjaiful Arifin was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.
Reported Earnings • Apr 08Full year 2021 earnings released: EPS: Rp15.00 (vs Rp15.75 in FY 2020)Full year 2021 results: EPS: Rp15.00 (down from Rp15.75 in FY 2020). Revenue: Rp397.3b (up 14% from FY 2020). Net income: Rp38.7b (down 2.8% from FY 2020). Profit margin: 9.7% (down from 11% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
Upcoming Dividend • May 31Upcoming dividend of Rp12.00 per shareEligible shareholders must have bought the stock before 07 June 2021. Payment date: 25 June 2021. Trailing yield: 4.2%. Lower than top quartile of Indonesian dividend payers (4.8%). Higher than average of industry peers (0.3%).
Reported Earnings • Apr 09Full year 2020 earnings released: EPS Rp16.00 (vs Rp12.83 in FY 2019)The company reported a solid full year result with improved earnings and profit margins, although revenues were flat. Full year 2020 results: Revenue: Rp350.0b (flat on FY 2019). Net income: Rp39.8b (up 23% from FY 2019). Profit margin: 11% (up from 9.3% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 6% per year.
Valuation Update With 7 Day Price Move • Feb 11Investor sentiment improved over the past weekAfter last week's 27% share price gain to Rp280, the stock is trading at a trailing P/E ratio of 22.3x, up from the previous P/E ratio of 17.5x. This compares to an average P/E of 16x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 40%.
Valuation Update With 7 Day Price Move • Dec 30Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to Rp232, the stock is trading at a trailing P/E ratio of 18.4x, down from the previous P/E ratio of 22.6x. This compares to an average P/E of 17x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 33%.
Valuation Update With 7 Day Price Move • Dec 18Investor sentiment improved over the past weekAfter last week's 33% share price gain to Rp238, the stock is trading at a trailing P/E ratio of 18.9x, up from the previous P/E ratio of 14.2x. This compares to an average P/E of 15x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 39%.
Is New 90 Day High Low • Dec 08New 90-day high: Rp180The company is up 7.0% from its price of Rp168 on 09 September 2020. The Indonesian market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 37% over the same period.
Valuation Update With 7 Day Price Move • Nov 28Market bids up stock over the past weekAfter last week's 18% share price gain to Rp179, the stock is trading at a trailing P/E ratio of 14.2x, up from the previous P/E ratio of 12.1x. This compares to an average P/E of 13x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 2.1%.
Is New 90 Day High Low • Nov 12New 90-day low: Rp140The company is down 10.0% from its price of Rp156 on 14 August 2020. The Indonesian market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.
Reported Earnings • Nov 03Third quarter 2020 earnings released: EPS Rp6.38The company reported a soft third quarter result with weaker earnings and revenues, although profit margins were improved. Third quarter 2020 results: Revenue: Rp94.8b (down 8.8% from 3Q 2019). Net income: Rp16.3b (down 2.6% from 3Q 2019). Profit margin: 17% (up from 16% in 3Q 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.